CMIC Holdings Co Ltd
TSE:2309

Watchlist Manager
CMIC Holdings Co Ltd Logo
CMIC Holdings Co Ltd
TSE:2309
Watchlist
Price: 999 999.9999 JPY 37 893.92% Market Closed
Market Cap: 47.6B JPY
Have any thoughts about
CMIC Holdings Co Ltd?
Write Note

CMIC Holdings Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CMIC Holdings Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
CMIC Holdings Co Ltd
TSE:2309
Cash Equivalents
ÂĄ11.9B
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
6%
C
Chiome Bioscience Inc
TSE:4583
Cash Equivalents
ÂĄ1.2B
CAGR 3-Years
-16%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
Precision System Science Co Ltd
TSE:7707
Cash Equivalents
ÂĄ1.9B
CAGR 3-Years
-22%
CAGR 5-Years
1%
CAGR 10-Years
-5%
Medinet Co Ltd
TSE:2370
Cash Equivalents
ÂĄ4.6B
CAGR 3-Years
2%
CAGR 5-Years
35%
CAGR 10-Years
6%
CellSource Co Ltd
TSE:4880
Cash Equivalents
ÂĄ4.8B
CAGR 3-Years
40%
CAGR 5-Years
80%
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Cash Equivalents
ÂĄ2.7B
CAGR 3-Years
28%
CAGR 5-Years
40%
CAGR 10-Years
N/A
No Stocks Found

CMIC Holdings Co Ltd
Glance View

Market Cap
47.6B JPY
Industry
Life Sciences Tools & Services

CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Intrinsic Value
1 134 940.8834 JPY
Undervaluation 12%
Intrinsic Value
Price

See Also

What is CMIC Holdings Co Ltd's Cash Equivalents?
Cash Equivalents
11.9B JPY

Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Cash Equivalents amounts to 11.9B JPY.

What is CMIC Holdings Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
6%

Over the last year, the Cash Equivalents growth was 3%. The average annual Cash Equivalents growth rates for CMIC Holdings Co Ltd have been 7% over the past three years , -5% over the past five years , and 6% over the past ten years .

Back to Top